Clinical Trial Update: A Study of Peginterferon Alfa-2b Combined With TDF in Patients With Chronic Hepatitis B [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating peginterferon alfa-2b combined with tenofovir disoproxil fumarate (TDF) in chronic hepatitis B has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Peginterferon alfa-2b (Peginterferon alfa-2b)
• TENOFOVIR DISOPROXIL FUMARATE (tenofovir disoproxil fumarate)

Snippet

Sponsor: Xiamen Amoytop Biotech Co., Ltd. | Conditions: Chronic Hepatitis B | Phase 3 | Status: COMPLETED